Advertisement
Advertisement
RLMD
Relmada Therapeutics, Inc. Common Stock
7.19
USDSponsored
-0.19
-2.57%
Apr 14, 16:00 UTC -4
Closed
Pre-Market
7.12
-0.07
-0.97%
Relmada Therapeutics, Inc. Common Stock Financial Snapshot
| Market Cap | 746.80M |
| Beta | 0.44 |
| Earnings Per Share (EPS) | -1.45 |
| Price-to-Book (P/B) Ratio | 6.45 |
| Operating Margin | -- |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -170.83% |
| Current Ratio | 14.62% |
| Free Cash Flow | -45.79M |
Trending Stocks
Advertisement